BGIM
HOLX

Boussard & Gavaudan Investment Management’s Hologic HOLX Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-117,910
Closed -$8.79M – 98
2025
Q4 		$8.79M Buy
+117,910
New +$8.62M 0.66% 42

Other funds holding HOLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Boussard & Gavaudan Investment Management's HOLX Position: Q1 2026 in Review

Boussard & Gavaudan Investment Management sold out of Hologic (HOLX) in Q1 2026, closing a stake of 117,910 shares — an estimated $8.79M sold.

Boussard & Gavaudan Investment Management first reported a position in HOLX in Q4 2025 and held it in 1 quarter. The position peaked at $8.79M in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Boussard & Gavaudan Investment Management reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 117,910 Hologic shares in Q1 2026, an estimated $8.79M.
  • Boussard & Gavaudan Investment Management first reported a position in Hologic in Q4 2025 and held it in 1 quarter.
  • Boussard & Gavaudan Investment Management's Hologic position peaked at $8.79M in Q4 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2026, filed 15 May 2026.